Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2014-09-19 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a stock buyback program. This action directly relates to the company trading its own stock, which corresponds to the 'Transaction in Own Shares' category. The text is very short and mentions reading the full announcement in PDF format, which might suggest RPA, but the core content is a direct report of share repurchase activity, making POS the most specific fit. Since the content is about the transaction itself, POS is preferred over RPA.
2014-09-19 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly corresponds to the company repurchasing or selling its own shares. The filing category 'Transaction in Own Shares' (POS) is the most appropriate fit for reporting share buybacks. Although the text mentions reading the full announcement in PDF format (suggesting RPA/RNS), the core subject matter is the transaction itself, and since the text provides the key transaction details (shares bought, value), POS is preferred over the general announcement codes, especially given the very short length which often implies a direct transaction report rather than just a notice of publication.
2014-09-12 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 99% confidence The document details specific transactions where Novozymes bought back its own B-shares under a previously announced share repurchase program (aktietilbagekøbsprogram). It provides transaction dates, quantities, average prices, and the total value of shares repurchased. This activity directly corresponds to the definition of a company buying back its own shares. The relevant filing type is 'Transaction in Own Shares' (POS). The document is a direct announcement of the transaction, not an announcement of a report (RPA) or a general regulatory filing (RNS).
2014-09-12 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program' announced previously. This action directly relates to the company acquiring its own shares. The filing category 'Transaction in Own Shares (POS)' is defined as the report of the company buying back or selling its own shares. Although the text is short and mentions reading the full announcement in PDF format (suggesting RPA/RNS), the core content is a direct update on the execution of a share repurchase program, making POS the most specific and accurate classification for the *content* described, even if it's a brief announcement of that transaction.
2014-09-05 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text is very short (401 characters) and describes a specific transaction: Novozymes buying back its own shares (aktietilbagekøbsprogram) up to a total value of 2 billion DKK during 2014. This directly relates to the company repurchasing its own stock. The final line, 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format), suggests this is a brief announcement rather than the full detailed report. The category 'Transaction in Own Shares' (POS) is the most appropriate fit for share repurchase activity. Given the brevity and the instruction to treat short announcements about reports as RPA/RNS, I must check if POS is a better fit than RPA. Since the content is specifically about share repurchase, POS is more precise than the general RPA/RNS fallback.
2014-09-05 Danish
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a stock buyback program. This directly relates to the company acquiring its own shares. The filing category 'Transaction in Own Shares' (POS) is the most appropriate fit for reporting share repurchases. Although it mentions reading the full announcement in PDF format (suggesting RPA/RNS), the core content is a direct report of a share transaction, making POS the primary classification, as the text itself contains the transaction data, not just an announcement of an attached report.
2014-08-29 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.